6 areas of UK health policy for Medtech to pay attention to

Pharma Market Access Insights - from Mtech Access

How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators?
Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) speaks to William Lee (Head of Policy and Compliance, British Healthcare Trades Association [BHTA]) about health policy, regulation and its implications for Medtech, Health technologies, and Medical Device market access.
With the challenges of the pandemic and the changes brought in following Brexit, policy and compliance in the UK has been on shifting sands for several years now. With many predicting a change in government at the next election, this continues to be a time of uncertainty. What does this political landscape mean for health policy, the regulatory regime and market access?
In this on-demand webinar, Rob asks Bill about 6 areas where Medtech should be paying attention:

• MHRA and new medical device regulatory regime
• UK health and social care supply and procurement
• Sustainability and social value
• Addressing capacity challenges with effective health and social care packages
• Innovation
• Export and import – the implications of Brexit

This episode was first broadcast as a live webinar in July 2023. Learn more about this webinar at: https://mtechaccess.co.uk/uk-health-policy-medtech-bhta-webinar/
Learn more about our services for Medtech companies at: https://mtechaccess.co.uk/medical-device-market-access/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

章

1. Welcome and introductions (00:00:00)

2. Key challenges Medtech companies consistently face (00:05:26)

3. MHRA and new medical device regulatory regime (00:11:03)

4. UK health and social care supply and procurement (00:27:25)

5. How can Medtech be part of the solution? (00:36:00)

6. Innovation and policy (00:45:14)

7. Export and import (Brexit implications) (00:52:34)